Business Description
DNA Group (TR) Ltd
ISIN : IL0011038523
Compare
Compare
Traded in other countries / regions
DNA.Israel IPO Date
2007-05-31Description
DNA Group (TR) Ltd invests in biomed companies and has also started to engage in profitable real estate in England.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.98 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 36.66 | |||||
Beneish M-Score | 5.11 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 29.8 | |||||
3-Year FCF Growth Rate | 33.1 | |||||
3-Year Book Growth Rate | 35.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.3 | |||||
9-Day RSI | 42.84 | |||||
14-Day RSI | 40.2 | |||||
6-1 Month Momentum % | 5.51 | |||||
12-1 Month Momentum % | 17.61 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 97.73 | |||||
Quick Ratio | 97.73 | |||||
Cash Ratio | 97.37 | |||||
Days Sales Outstanding | 305.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -58.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -710.46 | |||||
Net Margin % | -384.64 | |||||
FCF Margin % | -221.57 | |||||
ROE % | -1.46 | |||||
ROA % | -1.43 | |||||
ROIC % | -13.62 | |||||
ROCE % | -2.66 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 138.4 | |||||
PEG Ratio | 2.49 | |||||
PS Ratio | 346 | |||||
PB Ratio | 1.08 | |||||
Price-to-Tangible-Book | 1.08 | |||||
EV-to-EBIT | -8.52 | |||||
EV-to-EBITDA | -8.52 | |||||
EV-to-Revenue | 60.56 | |||||
EV-to-FCF | -30.78 | |||||
Price-to-Projected-FCF | 1.92 | |||||
Price-to-Peter-Lynch-Fair-Value | 13.84 | |||||
Price-to-Graham-Number | 2.56 | |||||
Price-to-Net-Current-Asset-Value | 1.31 | |||||
Price-to-Net-Cash | 1.31 | |||||
Earnings Yield (Greenblatt) % | -11.74 | |||||
FCF Yield % | -0.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DNA Group (TR) Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 0.306 | ||
EPS (TTM) (₪) | -0.01 | ||
Beta | 0 | ||
Volatility % | 63.27 | ||
14-Day RSI | 40.2 | ||
14-Day ATR (₪) | 0.031527 | ||
20-Day SMA (₪) | 0.7077 | ||
12-1 Month Momentum % | 17.61 | ||
52-Week Range (₪) | 0.56 - 1.1 | ||
Shares Outstanding (Mil) | 123.16 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
DNA Group (TR) Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
DNA Group (TR) Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
DNA Group (TR) Ltd Frequently Asked Questions
What is DNA Group (TR) Ltd(XTAE:DNA)'s stock price today?
The current price of XTAE:DNA is ₪0.69. The 52 week high of XTAE:DNA is ₪1.10 and 52 week low is ₪0.56.
When is next earnings date of DNA Group (TR) Ltd(XTAE:DNA)?
The next earnings date of DNA Group (TR) Ltd(XTAE:DNA) is .
Does DNA Group (TR) Ltd(XTAE:DNA) pay dividends? If so, how much?
DNA Group (TR) Ltd(XTAE:DNA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |